" class="no-js "lang="en-US"> Fabio Magrini - Medtech Alert
Monday, December 02, 2024
Fabio Magrini

Fabio Magrini

About Fabio Magrini

In my 20-years experience in industry, I have been consistently passionate about bringing clinical innovation, high quality standards and courageous leadership to all phases of drug development from translational medicine, PhI-III, and medical affairs. Over the course of my career I have initiated, designed, led, supported and implemented a large number of clinical programs in chronic inflammatory and autoimmune disease across several therapeutic areas including Neurology, Rheumatology, Nephrology, and Dermatology.
Over the last few years I have been developing an interest in integrative medicine approaches and patient focused outcomes, particularly applied to pharmaceutical development and clinical research.

Related Story

Aristea Therapeutics Announces Key Leadership Appointments to Advance its Clinical Pipeline

January 14 2022

Aristea Therapeutics (Aristea), a clinical-stage immunology focused drug development company advancing novel therapies to treat […]